Anlon Healthcare Merger & Restructuring
Anlon Healthcare incorporated ANLON Healthcare Nigeria Limited, holding 90% stake. The subsidiary aims to expand pharmaceutical and healthcare operations across 16 West African countries.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Anlon Healthcare incorporated ANLON Healthcare Nigeria Limited, holding 90% stake. The subsidiary aims to expand pharmaceutical and healthcare operations across 16 West African countries.
Anlon Healthcare will acquire significant stakes in Apiqo Organics (44.94%) and Bizotic Lifescience (47.41%) for a total consideration of approximately ₹153.30 Crore. Acquisitions involve a share swap via preferential issue.
Anlon Healthcare executed agreements to acquire stakes in Apiqo Organics and Bizotic Lifescience via share swaps. The AOPL acquisition is valued at approximately ₹116.52 Crore.
Anlon Healthcare incorporated a 65% subsidiary, Anlon Biologics Private Limited, for Rs. 0.065 Crore. The unit will manufacture surgical implants and biosimilars.
Anlon Healthcare incorporated a 55% subsidiary, Anlon Medicare Private Limited, for Rs. 0.11 Crore. The new unit will manufacture surgical implants and medical devices.